Results 1 - 20 of 18,556 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (15,800)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Correction to: Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by MetforminBMC cancer, 2021-08, Vol.21 (1), p.881-881, Article 881 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08584-z ;PMID: 34340683Full text available |
| 2 |
Material Type: Article
|
|
Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-[kappa]B Signaling PathwayFrontiers in oncology, 2020-09 [Peer Reviewed Journal]COPYRIGHT 2020 Frontiers Research Foundation ;ISSN: 2234-943X ;EISSN: 2234-943XFull text available |
| 3 |
Material Type: Article
|
|
Near-infrared light activatable hydrogels for metformin deliveryNanoscale, 2019-08, Vol.11 (34), p.15810-15820 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2040-3364 ;EISSN: 2040-3372 ;DOI: 10.1039/c9nr02707f ;PMID: 31270521Digital Resources/Online E-Resources |
| 4 |
Material Type: Article
|
|
Metformin Action: Concentrations MatterCell metabolism, 2015-02, Vol.21 (2), p.159-162 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2015.01.003 ;PMID: 25651170Full text available |
| 5 |
Material Type: Article
|
|
Low-dose metformin targets the lysosomal AMPK pathway through PEN2Nature (London), 2022-03, Vol.603 (7899), p.159-165 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 3, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04431-8 ;PMID: 35197629Full text available |
| 6 |
Material Type: Article
|
|
Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide BrambillaPharmaceutical research, 2017-12, Vol.34 (12), p.2614-2627 [Peer Reviewed Journal]The Author(s) 2017 ;ISSN: 0724-8741 ;EISSN: 1573-904X ;DOI: 10.1007/s11095-017-2199-y ;PMID: 28589443Full text available |
| 7 |
Material Type: Article
|
|
Metformin: New Preparations and Nonglycemic BenefitsCurrent Diabetes Reports, 2017, Vol.17 (1), p.5-5, Article 5 [Peer Reviewed Journal]Springer Science+Business Media New York 2017 ;Current Diabetes Reports is a copyright of Springer, 2017. ;ISSN: 1534-4827 ;EISSN: 1539-0829 ;DOI: 10.1007/s11892-017-0829-8 ;PMID: 28116648Full text available |
| 8 |
Material Type: Article
|
|
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysisAnnals of oncology, 2016-12, Vol.27 (12), p.2184-2195 [Peer Reviewed Journal]2016 THE AUTHORS ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2016 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw410 ;PMID: 27681864Full text available |
| 9 |
Material Type: Article
|
|
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trialEuropean heart journal, 2019-11, Vol.40 (41), p.3409-3417 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz203 ;PMID: 30993313Full text available |
| 10 |
Material Type: Article
|
|
Targeting immunometabolism as an anti-inflammatory strategyCell research, 2020-04, Vol.30 (4), p.300-314 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0291-z ;PMID: 32132672Full text available |
| 11 |
Material Type: Article
|
|
Metformin and the gastrointestinal tractDiabetologia, 2016-03, Vol.59 (3), p.426-435 [Peer Reviewed Journal]The Author(s) 2016 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-015-3844-9 ;PMID: 26780750Full text available |
| 12 |
Material Type: Article
|
|
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and ChallengesInternational journal of molecular sciences, 2021-12, Vol.23 (1), p.398 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms23010398 ;PMID: 35008822Full text available |
| 13 |
Material Type: Article
|
|
Clinical Pharmacokinetics of MetforminClinical pharmacokinetics, 2011-02, Vol.50 (2), p.81-98 [Peer Reviewed Journal]Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International Feb 2011 ;ISSN: 0312-5963 ;EISSN: 1179-1926 ;DOI: 10.2165/11534750-000000000-00000 ;PMID: 21241070 ;CODEN: CPKNDHFull text available |
| 14 |
Material Type: Article
|
|
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyDiabetes, obesity & metabolism, 2011, Vol.13 (1), p.65-742010 Blackwell Publishing Ltd ;2010 Blackwell Publishing Ltd. ;Copyright Wiley Subscription Services, Inc. Jan 2011 ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/j.1463-1326.2010.01326.x ;PMID: 21114605Full text available |
| 15 |
Material Type: Article
|
|
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4Diabetes care, 2018-03, Vol.41 (3), p.547-553 [Peer Reviewed Journal]2018 by the American Diabetes Association. ;Copyright American Diabetes Association Mar 1, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-2231 ;PMID: 29305402Full text available |
| 16 |
Material Type: Article
|
|
Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomesAging cell, 2022-01, Vol.21 (1), p.e13093-n/a [Peer Reviewed Journal]2022 The Authors. published by the Anatomical Society and John Wiley & Sons Ltd. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1474-9718 ;EISSN: 1474-9726 ;DOI: 10.1111/acel.13093 ;PMID: 35032421Full text available |
| 17 |
Material Type: Article
|
|
A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapyNature nanotechnology, 2016-06, Vol.11 (6), p.566-572 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 2016 ;ISSN: 1748-3387 ;EISSN: 1748-3395 ;DOI: 10.1038/NNANO.2016.38 ;PMID: 26999482Full text available |
| 18 |
Material Type: Article
|
|
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trialThe Lancet (British edition), 2019-07, Vol.394 (10192), p.39-50 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31271-1 ;PMID: 31186120Full text available |
| 19 |
Material Type: Article
|
|
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin TherapyCell, 2019-09, Vol.178 (6), p.1299-1312.e29 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2019.08.003 ;PMID: 31474368Full text available |
| 20 |
Material Type: Article
|
|
Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidneyThe Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.393-403 [Peer Reviewed Journal]ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.111.184986 ;PMID: 22072731Full text available |
Results 1 - 20 of 18,556 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (15,800)
Refine My Results
Creation Date
- Before 1975 (63)
- 1975 To 1986 (91)
- 1987 To 1998 (387)
- 1999 To 2011 (3,789)
- After 2011 (14,192)
-
More options
New Records
- New From Last Month (33)
- New From Last 3 Month (202)
-
More options
Resource Type
- Articles (18,063)
- Thesises (postgraduate) (141)
- magazinearticle (100)
- Web Resources (86)
- Reports (47)
- Book Chapters (41)
- Newsletter Articles (29)
- Books (22)
- Conference Proceedings (13)
- Text Resources (6)
- Datasets (4)
- Newspaper Articles (2)
- References (2)
-
More options
Subject
- Science & Technology (13,633)
- Metformin (13,577)
- Life Sciences & Biomedicine (12,631)
- Humans (9,025)
- Diabetes (5,857)
- Female (5,284)
- Metformin - Therapeutic Use (5,149)
- Male (4,646)
- Diabetes Mellitus (4,214)
- Hypoglycemic Agents - Therapeutic Use (3,972)
- Diabetes Mellitus, Type 2 - Drug Therapy (3,796)
- Endocrinology & Metabolism (3,662)
- Metformin - Pharmacology (3,103)
- Middle Aged (3,037)
- Animals (2,979)
- Type 2 Diabetes (2,875)
- Insulin (2,872)
- Glucose (2,645)
- Adult (2,456)
- Insulin Resistance (2,319)
-
More options
Databases
- MEDLINE (10,696)
- ProQuest Central (9,851)
- GFMER Free Medical Journals (8,394)
- PubMed Central (8,216)
- DOAJ Directory of Open Access Journals (7,726)
- ROAD: Directory of Open Access Scholarly Resources (6,107)
- HighWire Press (Free Journals) (2,571)
- Springer Nature OA/Free Journals (1,212)
- Wiley Online Library Open Access (837)
- Nature Open Access (543)
- ProQuest One Psychology (540)
- Public Library of Science (PLoS) Journals Open Access (449)
- Taylor & Francis Open Access (435)
- Journals@Ovid Open Access Journal Collection Rolling (405)
- IngentaConnect Free/Open Access Journals (313)
- Free E- Journals (292)
- DOVE Medical Press Journals (230)
- Coronavirus Research Database (223)
- Medknow Open Access Medical Journals (221)
- SWEPUB Freely available online (179)
-
More options
Language
Journal Title
- Diabetes (538)
- Diabetes Care (591)
- Diabetes, Obesity & Metabolism (393)
- Diabetic Medicine (195)
- Diabetologia (213)
- International Journal Of Molecular Sciences (260)
- Oncotarget (150)
- Plos One (427)
- Scientific Reports (264)
- The Journal Of Clinical Endocrinology And Metabolism (232)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||